Catherine Pearce
Director/Board Member at Bexion Pharmaceuticals, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ray Takigiku | M | - |
Bexion Pharmaceuticals, Inc.
 Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bexion Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of oncology treatments. The firm is developing BXQ-350, a first-in-class agent composed of the multifunctional, lysosomal activator protein Saposin C and phosphatidylserine. The company was founded by Ray Takigiku in 2006 and is headquartered in Covington, KY. | 18 years |
| Jonathan Isaacsohn | M | 70 |
CinRx Pharma LLC
 CinRx Pharma LLC Pharmaceuticals: MajorHealth Technology CinRx Pharma LLC develops biopharmaceutical products. It provides therapeutics in a novel way that meets the modern paradigm of drug development. The company was founded by Jonathan L. Isaacsohn in 2015 and is headquartered in Cincinnati, OH. | 9 years |
| Sol Barer | M | 76 | 9 years | |
| Scott R. Shively | M | 67 |
Bexion Pharmaceuticals, Inc.
Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bexion Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of oncology treatments. The firm is developing BXQ-350, a first-in-class agent composed of the multifunctional, lysosomal activator protein Saposin C and phosphatidylserine. The company was founded by Ray Takigiku in 2006 and is headquartered in Covington, KY. | - |
| Marc M. P. de Garidel | M | 66 | 3 years | |
| Mason W. Freeman | M | 73 | 3 years | |
| Rosemary Crane | F | 64 | 9 years | |
| Gerald Lieberman | M | 77 | 9 years | |
| Olivia Kirtley | F | 74 |
Bexion Pharmaceuticals, Inc.
Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bexion Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of oncology treatments. The firm is developing BXQ-350, a first-in-class agent composed of the multifunctional, lysosomal activator protein Saposin C and phosphatidylserine. The company was founded by Ray Takigiku in 2006 and is headquartered in Covington, KY. | 3 years |
| Nir Baron | M | - | 10 years | |
| Hema Keshava | F | - | 3 years | |
| Chuck Scheper | M | - |
Bexion Pharmaceuticals, Inc.
Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bexion Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of oncology treatments. The firm is developing BXQ-350, a first-in-class agent composed of the multifunctional, lysosomal activator protein Saposin C and phosphatidylserine. The company was founded by Ray Takigiku in 2006 and is headquartered in Covington, KY. | - |
| Yonatan Beker | M | - | 11 years | |
| Catherine Pearce | F | - |
CinRx Pharma LLC
CinRx Pharma LLC Pharmaceuticals: MajorHealth Technology CinRx Pharma LLC develops biopharmaceutical products. It provides therapeutics in a novel way that meets the modern paradigm of drug development. The company was founded by Jonathan L. Isaacsohn in 2015 and is headquartered in Cincinnati, OH. | 9 years |
| Justin Thompson | M | - | 3 years | |
| Jim Beach | M | - |
Bexion Pharmaceuticals, Inc.
Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bexion Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of oncology treatments. The firm is developing BXQ-350, a first-in-class agent composed of the multifunctional, lysosomal activator protein Saposin C and phosphatidylserine. The company was founded by Ray Takigiku in 2006 and is headquartered in Covington, KY. | - |
| Timothy Schroeder | M | 66 |
Bexion Pharmaceuticals, Inc.
Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bexion Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of oncology treatments. The firm is developing BXQ-350, a first-in-class agent composed of the multifunctional, lysosomal activator protein Saposin C and phosphatidylserine. The company was founded by Ray Takigiku in 2006 and is headquartered in Covington, KY. | - |
| Margaret M. van Gilse | F | - |
Bexion Pharmaceuticals, Inc.
Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bexion Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of oncology treatments. The firm is developing BXQ-350, a first-in-class agent composed of the multifunctional, lysosomal activator protein Saposin C and phosphatidylserine. The company was founded by Ray Takigiku in 2006 and is headquartered in Covington, KY. | - |
| Cameron Durrant | M | 63 |
Bexion Pharmaceuticals, Inc.
Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bexion Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of oncology treatments. The firm is developing BXQ-350, a first-in-class agent composed of the multifunctional, lysosomal activator protein Saposin C and phosphatidylserine. The company was founded by Ray Takigiku in 2006 and is headquartered in Covington, KY. | - |
| Raymond Tesi | M | 68 |
Bexion Pharmaceuticals, Inc.
Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bexion Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of oncology treatments. The firm is developing BXQ-350, a first-in-class agent composed of the multifunctional, lysosomal activator protein Saposin C and phosphatidylserine. The company was founded by Ray Takigiku in 2006 and is headquartered in Covington, KY. | 4 years |
| Keith A Carlson | M | - |
Bexion Pharmaceuticals, Inc.
Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bexion Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of oncology treatments. The firm is developing BXQ-350, a first-in-class agent composed of the multifunctional, lysosomal activator protein Saposin C and phosphatidylserine. The company was founded by Ray Takigiku in 2006 and is headquartered in Covington, KY. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jon Isaacsohn | M | - | - | |
| Phillip Frost | M | 87 | 9 years | |
| Troy Ignelzi | M | 56 | 2 years | |
| Felicia Ladin | F | 52 | 6 years | |
| Marcelo Bigal | M | - | 4 years | |
| Michael Kalb | M | 53 | 1 years | |
| Chaim Hurvitz | M | 63 | 15 years | |
| Dafna Schwartz | M | 73 | 3 years | |
| Isaac Abravanel | M | 70 | 7 years | |
| June Lee | M | 58 | - | |
| John Thero | M | 63 | 2 years | |
| James Healy | M | 58 | 4 years | |
| Jean-Michael Halfon | M | 72 | 9 years | |
| Jeremy Levin | M | 70 | 1 years | |
| Inbal Benjamini-Elran | F | - | 4 years | |
| Abi Vainstein-Haras | M | 49 | 7 years | |
| Michael McClellan | M | 54 | 4 years | |
| Mary Coelho | F | 62 | 1 years | |
| Deborah L. Schmalz | F | - |
Medpace, Inc.
 Medpace, Inc. Miscellaneous Commercial ServicesCommercial Services Medpace, Inc. provides clinical research services to the pharmaceutical, biotech and medical industries. It offers clinical operations, medical writing, biometrics, regulatory affairs, quality assurance, imaging core lab medical device and risk based monitoring services. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH. | 4 years |
| John Nason | M | - | 7 years | |
| Gianfranco Nazzi | M | - | 7 years | |
| Jason Pitts | M | 38 | 2 years | |
| Ernesto Aycardi | M | 61 | 4 years | |
| Hadas Dreiher-Horowitz | F | 47 | 5 years | |
| Jean-Marc Hagai | M | - | 6 years | |
| Ariella Raban | F | 48 | 7 years | |
| Ann Cunningham | F | 56 | 3 years | |
| Ferenc Tracik | M | 60 | 4 years | |
| Ralph Laufer | M | - | 5 years | |
| Béatrice Bihr | F | - | 6 years | |
| John Jacobs | M | 57 | 3 years | |
| Piyush Patel | M | 59 |
CinRx Pharma LLC
CinRx Pharma LLC Pharmaceuticals: MajorHealth Technology CinRx Pharma LLC develops biopharmaceutical products. It provides therapeutics in a novel way that meets the modern paradigm of drug development. The company was founded by Jonathan L. Isaacsohn in 2015 and is headquartered in Cincinnati, OH. | 5 years |
| Andrew Weil | M | 56 | 7 years | |
| Ilana Fahima | F | 58 | 9 years | |
| Esther Lukasiewicz-Hagai | M | - | 1 years | |
| Timothy Wright | M | 66 | 2 years | |
| David Allison | M | 42 | 4 years | |
| Dan Suesskind | M | 80 | 4 years | |
| Richard Alan Lerner | M | 85 | 3 years | |
| Bruce Brown | M | 65 |
Medpace, Inc.
Medpace, Inc. Miscellaneous Commercial ServicesCommercial Services Medpace, Inc. provides clinical research services to the pharmaceutical, biotech and medical industries. It offers clinical operations, medical writing, biometrics, regulatory affairs, quality assurance, imaging core lab medical device and risk based monitoring services. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH. | 3 years |
| Larry R. Downey | M | 71 | - | |
| Robert Koremans | M | 61 | 4 years | |
| Lori Queisser | F | 63 | - | |
| David Stamler | M | 63 | 2 years | |
| Maina Bhaman | M | 52 | 4 years | |
| August Troendle | M | 67 | 3 years | |
| Alexander Leslie | M | 45 |
Medpace, Inc.
Medpace, Inc. Miscellaneous Commercial ServicesCommercial Services Medpace, Inc. provides clinical research services to the pharmaceutical, biotech and medical industries. It offers clinical operations, medical writing, biometrics, regulatory affairs, quality assurance, imaging core lab medical device and risk based monitoring services. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH. | 3 years |
| Shmuel Ben Zvi | M | 64 | 10 years | |
| Ron Grupel | M | 73 | 21 years | |
| Glynis Neagle | M | - |
Medpace, Inc.
Medpace, Inc. Miscellaneous Commercial ServicesCommercial Services Medpace, Inc. provides clinical research services to the pharmaceutical, biotech and medical industries. It offers clinical operations, medical writing, biometrics, regulatory affairs, quality assurance, imaging core lab medical device and risk based monitoring services. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH. | - |
| Matthew Norton | M | - |
Medpace, Inc.
Medpace, Inc. Miscellaneous Commercial ServicesCommercial Services Medpace, Inc. provides clinical research services to the pharmaceutical, biotech and medical industries. It offers clinical operations, medical writing, biometrics, regulatory affairs, quality assurance, imaging core lab medical device and risk based monitoring services. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH. | 2 years |
| Frances M. Zipp | F | - | 6 years | |
| Jill DeSimone | F | 68 | 2 years | |
| Kobi Altman | M | 55 | 9 years | |
| Paul Sekhri | M | 65 | 1 years | |
| Itay Dromi | M | 59 | 4 years | |
| Richard Malamut | M | 64 | 3 years | |
| Orit Pinchuk | F | 59 | 21 years | |
| Hanadi Said | F | 47 | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Israel | 47 | 58.75% |
| United States | 33 | 41.25% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Catherine Pearce
- Personal Network